Germ cells tumors most frequently occur in the gonads. Extragonadal localization is rare and concerns mainly midline locations such as the mediastinum, retroperitoneum, and pineal gland. Yolk sac tumor (YST) is a malignant tumor originating from the germ cell. Gastric adenocarcinoma with a yolk sac component is extremely rare with only a few cases reported in the literature \[[@ref1]\].

Herein, we present a rare case of gastric cancer with adenocarcinoma and YST components in a 68-year-old woman who presented with metastatic para-aortic lymphadenopathy (LAP).

CASE REPORT {#sec1-2}
===========

A 68-year-old woman presented with symptoms of appetite loss, weight loss, and abdominal pain that had persisted for 4 months. During a general health examination at a local clinic, para-aortic LAP was detected by abdominal tomography. Tru-Cut biopsy revealed adenocarcinoma with probable primary ovarian or other serosal origin. She was referred to our hospital for further evaluation and management. There was no significant physical findings. Except for anemia (level of hemoglobin: 11.1 g/dl), hematological and biochemical parameters were normal. The level of alpha-fetoprotein (AFP) in her serum was elevated to 50 ng/mL (normal: 0--32 ng/mL), whereas levels of carcinoembryonic antigen (CEA) (normal: 0--3 ng/mL), and human chorionic gonadotropin (HCG) (normal: 0--10 mlU/ml) in the serum were within the normal limits. Computed tomography of the abdomen showed gastric wall thickness at the lesser curvature of the mid body in addition to para-aortic lymph node enlargement. Upper digestive tract endoscopy showed a 5--6 cm-ulcerofungating mass in the lesser curvature of the gastric body. Histopathologic findings following gastroduodenoscopy revealed an invasive poorly differantiated adenocarcinoma. Total gastrectomy with D2 lymph node dissection and esophagojejunostomy were performed. Precise histopathological examination of resected specimens revealed the presence of a moderate-to-poorly differentiated invasive adenocarcinoma, with features of YST. An elevated tumor, 6×5×3 cm in size, with surface ulceration and hemorrhage was located in the antral minor curvature of the stomach. The tumor was primarily located in the mucosa and submucosa. The final diagnosis was T3, N3, M0, and stage III according to the Japanese classification of gastric cancer. Metastases to perigastric lymph nodes were also observed. The gastric tumor was composed of two histological types: YST and a moderately differentiated tubular adenocarcinoma. Majority of the tumor was occupied by a YST which showed the most common reticular pattern ([Fig. 1A](#F1){ref-type="fig"}, [Fig. 1B](#F1){ref-type="fig"}). Schiller-Duval bodies were also sporadically observed. Other components of germ cell tumors, like embryonal carcinomas and choriocarcinomas, were not identified. In the yolk sac component, tumor cells showed immunoreactivity for cytokeratin ([Fig. 1C](#F1){ref-type="fig"}) and AFP ([Fig. 1D](#F1){ref-type="fig"}) but not for CEA, chromogranin A, cytokeratins 7 and 20, β-HCG, CDX2, placental alkaline phosphatase, and CD30. Focal staining for AFP was also observed in the adenocarcinoma foci ([Fig. 2](#F2){ref-type="fig"}). Alternatively, CEA was strongly positive in the adenocarcinoma. The postoperative period was uneventful, and the patient was discharged on the 9 th postoperative day with a plan for chemotherapy. The patient died in 8 months after the surgery.

![Morphological features of yolk sac tumor (A). Tumor with reticular pattern adjacent the gastric foveolar epithelium (B). Tumor cells, with pale eosinophilic cytoplasm and vesicular nuclei, appear to be arranged into microcystic and papillary or pseudopapillary structures. The tumor cells show immunoreactivity for cytokeratin (C) and for AFP (D).](NCI-4-275-g001){#F1}

![The adenocarcinomatous component of the tumor shows atypical tubular glands with luminal necrotic material (A). Focal AFP immunostaining in the adenocarcinoma component (B).](NCI-4-275-g002){#F2}

DISCUSSION {#sec1-3}
==========

Gastric cancer remains one of the deadly diseases with poor prognosis. Sixteen cases of gastric YST have been reported in the medical literature since the description of the tumor in 1985 by Gharcia et al. ([Table 1](#T1){ref-type="table"}). It is notable that 11 cases (68.75%) have been reported to have adenocarcinoma components as well. The level of AFP in the serum was increased in most of these cases \[[@ref2]\]. Six of the 16 patients with gastric YST had rapidly fatal clinical courses, consistent with the highly aggressive nature of these neoplasms at other sites. According to reported literature, gastric YST usually affect middle-aged and elderly people with male preponderance, as confirmed by our case. They are aggressive neoplasms with early metastases. Five of the reported patients had long-term survival and one was a autopsy case. The remaining four patients had short survival times. The clinical presentation in most patients is remarkably uniform. YSTs of the stomach that have been reported to be large masses within the stomach. Although there has been at least one report of YST that did not respond at all to germ cell regimens, YSTs of the stomach should be treated with germ cell regimens, such as bleomycin, etoposide, and cisplatin or vinblastine, ifosfamide, and cisplatine. However, the adenocarcinomatous components may not be as responsive as the germ cell tumors. The disease tends to rapidly recur in spite of initial response to chemotherapy. Controversy remains regarding the origin of extragonadal germ cell tumors. These tumors can be found anywhere on the midline, particularly the retroperitoneum, anterior mediastinum, sacrococcyx, and pineal gland. Other less common sites include the orbit, suprasellar area, palate, thyroid, submandibular region, anterior abdominal wall, stomach, liver, vagina, gallbladder, pancreas, and prostate \[[@ref3]\]. The classic theory suggests that germ cell tumors in these areas are derived from migrating germ cells sequestered in the midline during embryogenesis \[[@ref4]\]. This may be the case of pure YSTs occurring in the stomach \[[@ref5]--[@ref8]\]. An alternative theory suggests that the tumor originates due to aberrant differentiation of somatic cells \[[@ref9], [@ref10]\]. This might explain cases of YST occurring in the stomach or lung. Aberrant differentiation of adenocarcinomas may explain the development of gastric YST with a adenocarcinomatous component, as observed in the present case.

###### 

Summary of reported gastric yolk sac tumors

  Authors (year)          Age/Sex   Location       Tumor (cm)     Therapy      Histology     Metastasis                  Prognosis
  ----------------------- --------- -------------- -------------- ------------ ------------- --------------------------- -------------------------------------------------------------
  Garcia & Ghali (1985)   65/M      Antrum         5              NT           YST, CC, AC   Liver                       Autopsy case
  Motoyama (1985)         72/F      Body           10.5x9.5x8.5   S            YST, AC       None                        Survival for 3 years
  Motoyama (1993)         72/F      NM             7x6                         YST, AC, CC   None                        Died in 3 years
  Zamecnik (1993)         88/M      Antrum         NM             S            YST           LN, omentum, retropyloric   Died in 4 weeks
  Suzuki (1999)           56/M      Cardia         15x10x7        S, CT        YST, AC       LN, abdominal cavity        Died in 6 weeks
  Puglisi (1999)          61/M      Antrum         6              NT           YST, AC       Abdominal cavity            Died in 1 month
  Wang (2000)             36/M      Body           NM             CT           YST, AC       LN, lung, spinal cord       Died in 6 months
  Napaki (2004)           38/F      E-G junction   NM             S, CT        YST, AC       Liver                       Survived for 32 months
  Kanai (2005)            87/M      Cardia         3x3            S            YST           LN                          Died in 7 months
  Singh (2007)            67/M      Body, antrum   8x10           S, CT        YST, AC       LN                          Died in 2 months
  Hong (2007)             50/M      Antrum         4.5x3          S            YST, AC       None                        Survived for 12 months
  Tahara (2008)           74/M      Body           5x3.5          NT           YST           LN, liver, O                Died in 6 days
  Gupta (2008)            67/M      NM             NM             S, CT        YST, AC, CC   Liver, lung                 Death during adjuvan CT
  Kim (2009)              61/M      Body           1x0.8          S            YST           None                        No recurrence and good condition for 3 months after surgery
  Magni (2010)            62/M      Antrum         7              S, CT        YST           None                        Died in 12 months
  Satake (2011)           74/M      Body, antrum   11x8x3         S, RFA, CT   YST, CC, AC   LN, liver, O, pancreas      Recurrence in 6 months
  Present case            68/F      Body           5x6            S, CT        YS, AC        LN                          Died in 8 months

YST: Yolk sac tumor; AC: Adenocarcinoma; CC: Choriocarcinoma; LN: Lymph node; O: Omentum; NM: Not mentioned; NT: No treatment; S: Surgery; CT: Chemotherapy; RFA: Radiofrequency ablation.

CONCLUSION {#sec1-4}
==========

In patients with gastric carcinoma with a high level of AFP in the serum, YST is the likely diagnosis. Although the reported number of gastric adenocarcinomas with a yolk sac component is not so large to predict a proper outcome, the presence of the yolk sac component may be an indication of poor prognosis in terms of duration of survival.
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